MUSTANG BIO, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MUSTANG BIO, INC. stock issued during period, value, new issues for the quarter ending 2020-12-31 was $55.00K.
- MUSTANG BIO, INC. stock issued during period, value, new issues for the quarter ending 2020-09-30 was -$137.00K, a 363.46% decline year-over-year.
- MUSTANG BIO, INC. stock issued during period, value, new issues for the quarter ending 2020-06-30 was $34.92M, a 18.45% increase year-over-year.
- MUSTANG BIO, INC. stock issued during period, value, new issues for the quarter ending 2019-12-31 was $0.00.
- MUSTANG BIO, INC. stock issued during period, value, new issues for fiscal 2020 was $34.84M, a 17.96% increase from fiscal 2019.
- MUSTANG BIO, INC. stock issued during period, value, new issues for fiscal 2019 was $29.54M.
- MUSTANG BIO, INC. stock issued during period, value, new issues for fiscal 2017 was $55.97M, a 43.15% increase from fiscal 2016.
- MUSTANG BIO, INC. stock issued during period, value, new issues for fiscal 2016 was $39.10M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2020-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $34.84M 10-K · filed 2022-03-23 |
| 2020-09-30 | -$137.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $34.92M 10-Q · filed 2021-08-16 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $29.54M 10-K · filed 2021-03-24 |
| 2019-09-30 | $52.00K 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $29.48M 10-Q · filed 2019-08-09 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $55.97M 10-K · filed 2019-03-18 |
| 2017-09-30 | $65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $82.62M derived: sum of 4 quarters · filed 2018-03-29 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | |
| 2017-03-31 | $55.91M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $26.65M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $39.10M 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |